GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (HKSE:01177) » Definitions » Cyclically Adjusted PB Ratio

Sino Biopharmaceutical (HKSE:01177) Cyclically Adjusted PB Ratio : 2.67 (As of May. 27, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Sino Biopharmaceutical Cyclically Adjusted PB Ratio?

As of today (2024-05-27), Sino Biopharmaceutical's current share price is HK$2.91. Sino Biopharmaceutical's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was HK$1.09. Sino Biopharmaceutical's Cyclically Adjusted PB Ratio for today is 2.67.

The historical rank and industry rank for Sino Biopharmaceutical's Cyclically Adjusted PB Ratio or its related term are showing as below:

HKSE:01177' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.15   Med: 10.04   Max: 23.38
Current: 2.64

During the past 13 years, Sino Biopharmaceutical's highest Cyclically Adjusted PB Ratio was 23.38. The lowest was 2.15. And the median was 10.04.

HKSE:01177's Cyclically Adjusted PB Ratio is ranked worse than
62.23% of 654 companies
in the Biotechnology industry
Industry Median: 1.73 vs HKSE:01177: 2.64

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sino Biopharmaceutical's adjusted book value per share data of for the fiscal year that ended in Dec23 was HK$1.773. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$1.09 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sino Biopharmaceutical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sino Biopharmaceutical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Cyclically Adjusted PB Ratio Chart

Sino Biopharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.02 12.79 7.07 4.92 3.19

Sino Biopharmaceutical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.07 - 4.92 - 3.19

Competitive Comparison of Sino Biopharmaceutical's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Sino Biopharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biopharmaceutical's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Cyclically Adjusted PB Ratio falls into.



Sino Biopharmaceutical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sino Biopharmaceutical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.91/1.09
=2.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sino Biopharmaceutical's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Sino Biopharmaceutical's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=1.773/117.2957*117.2957
=1.773

Current CPI (Dec23) = 117.2957.

Sino Biopharmaceutical Annual Data

Book Value per Share CPI Adj_Book
201412 0.397 99.707 0.467
201512 0.468 102.015 0.538
201612 0.531 103.225 0.603
201712 0.654 104.984 0.731
201812 0.782 107.622 0.852
201912 0.881 110.700 0.933
202012 1.053 109.711 1.126
202112 1.969 112.349 2.056
202212 1.766 114.548 1.808
202312 1.773 117.296 1.773

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sino Biopharmaceutical  (HKSE:01177) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sino Biopharmaceutical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biopharmaceutical (HKSE:01177) Business Description

Traded in Other Exchanges
Address
1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.
Executives
Tse Eric S Y 2101 Beneficial owner
Tse Ping 2101 Beneficial owner
Cheng Cheung Ling 2101 Beneficial owner
True Merit Global Limited 2101 Beneficial owner
Tse Theresa Y Y 2101 Beneficial owner
Thousand Eagles Limited 2101 Beneficial owner
France Investment (china 1) Group Limited 2101 Beneficial owner
Remarkable Industries Limited 2101 Beneficial owner
Validated Profits Limited 2101 Beneficial owner

Sino Biopharmaceutical (HKSE:01177) Headlines

No Headlines